CMMB - CIK 0001534248
Chemomab Therapeutics Ltd. trades as CMMB. This page tracks Chemomab Therapeutics Ltd. through 347 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-14 |
| 6-K | - | 2026-05-06 |
| 6-K | - | 2026-04-28 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
The largest companies sharing Chemomab Therapeutics Ltd.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Chemomab Therapeutics Ltd. reported a net loss of $8.99M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.